Raia Drogasil S.A. (OTCMKTS:RADLY) Shares Shorted: Short Interest Down 40.3% in October

Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totaling 793 shares, a decrease of 40.3% from the September 30th total of 1,328 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 349,085 shares, the days-to-cover ratio is currently 0.0 days.

Analysts Set New Price Targets

Separately, Jefferies Financial Group upgraded Raia Drogasil to a “buy” rating and set a $5.20 price target for the company in a report on Sunday, October 18th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $5.20.

Check Out Our Latest Stock Report on Raia Drogasil

Raia Drogasil Stock Performance

RADLY opened at $2.85 on Tuesday. The firm has a market capitalization of $3.75 billion and a PE ratio of 19.00. The firm has a 50 day moving average of $3.74 and a two-hundred day moving average of $4.07. Raia Drogasil has a 12-month low of $2.74 and a 12-month high of $5.34. The company has a current ratio of 1.41, a quick ratio of 0.58 and a debt-to-equity ratio of 0.99.

Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.05. The firm had revenue of $2.17 billion during the quarter, compared to analysts’ expectations of $2.32 billion. Raia Drogasil had a net margin of 2.99% and a return on equity of 20.12%. On average, analysts anticipate that Raia Drogasil will post 0.17 EPS for the current year.

Raia Drogasil Company Profile

(Get Free Report)

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.

See Also

Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.